沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09996 沛嘉医疗-B

未开盘 10-14 16:08:26

4.375

-0.020

-0.46%

最高4.460	最低4.150	成交量67.60万
今开4.405	昨收4.395	日振幅7.05%
总市值29.62亿	流通市值29.62亿	总股本6.77亿
成交额294.85万	换手率0.10%	流通股本6.77亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09996","market":"HK","secType":"STK","nameCN":"沛嘉医疗-B","latestPrice":4.375,"timestamp":1791965306010,"preClose":4.395,"halted":0,"volume":676000,"delay":0,"changeRate":-0.004550625711035171,"floatShares":677000000,"shares":677000000,"eps":-0.35830641722909345,"marketStatus":"未开盘","change":-0.02,"latestTime":"10-14 16:08:26","open":4.405,"high":4.46,"low":4.15,"amount":2948490,"amplitude":0.070535,"askPrice":4.375,"askSize":13000,"bidPrice":4.3,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-0.24770978026902313,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792027800000},"marketStatusCode":0,"adr":0,"listingDate":1589472000000,"exchange":"SEHK","adjPreClose":4.395,"openAndCloseTimeList":[[1791941400000,1791950400000],[1791954000000,1791964800000]],"volumeRatio":1.2349287539524205,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09996","defaultTab":"news","newsList":[{"id":"2675241753","title":"股市必读：宝莱特新发布《关于公司获得医疗器械注册证的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2675241753","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675241753?lang=zh_cn&edition=full","pubTime":"2026-10-15 03:29","pubTimestamp":1792006149,"startTime":"0","endTime":"0","summary":"公司公告汇总：宝莱特近日获国家药监局颁发《医疗器械注册证》，产品为病人监护仪，属Ⅲ类医疗器械，有效期至2031年10月8日。公司公告汇总关于公司获得医疗器械注册证的公告广东宝莱特医用科技股份有限公司近日获得国家药监局颁发的《医疗器械注册证》，产品名称为病人监护仪，型号包括G10、G10A、G10B、G10C、G12、G12A、G12B、G12C、G15、G15A、G15B、G15C，注册证编号为国械注准20263072105，有效期至2031年10月8日，属于Ⅲ类医疗器械。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500003644.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","09996","159883","BK1574","BK0146","BK1583","300246","BK0070","BK1100","BK0114","BK0028","BK0181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675367459","title":"从引进一家企业到上百家企业入驻宁乡生命科学产业集群初见雏形","url":"https://stock-news.laohu8.com/highlight/detail?id=2675367459","media":"滚动播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675367459?lang=zh_cn&edition=full","pubTime":"2026-10-14 04:44","pubTimestamp":1791924240,"startTime":"0","endTime":"0","summary":"湖南省宁乡经开区相关负责人说，宁乡生命科学产业集群已初具规模。随着楚天科技在医药装备产业方面的发展壮大，医药装备产业聚集效应形成，宁乡市决定涉足生命科学产业。医疗器械产业是生命科学产业的重要组成部分。宁乡制造业的集聚效应显现，吸引了一批医疗器械企业落地宁乡。记者了解到，宁乡正积极招商国内更多医疗器械行业企业落户，宁乡生命科学产业的生态拼图将越发完整。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-10-14/doc-inivcpit7257894.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["PTH","BK1100","BK1574","HART","LNGR","BK1583","RSPH","LGHT","AGNG","MEDX","IEIH","GDOC","09996","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675569364","title":"股市必读：科华生物新发布《关于产品获得医疗器械注册证的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2675569364","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675569364?lang=zh_cn&edition=full","pubTime":"2026-10-14 03:09","pubTimestamp":1791918550,"startTime":"0","endTime":"0","summary":"截至2026年10月13日收盘，科华生物报收于6.12元，上涨0.82%，换手率1.98%，成交量10.2万手，成交额6160.78万元。当日关注点交易信息汇总：10月13日主力资金净流出188.17万元，占总成交额3.05%。公司公告汇总：控股子公司苏州天隆获诺如病毒GⅠ和GⅡ型核酸分型检测试剂盒医疗器械注册证，有效期至2031年10月08日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400002121.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002022","BK1583","BK1574","BK1100","BK0188","159883","BK0046","BK0239","BK0028","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675361086","title":"股市必读：圣湘生物新发布《圣湘生物科技股份有限公司关于自愿披露相关产品取得医疗器械注册证的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2675361086","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675361086?lang=zh_cn&edition=full","pubTime":"2026-10-14 02:53","pubTimestamp":1791917587,"startTime":"0","endTime":"0","summary":"截至2026年10月13日收盘，圣湘生物报收于16.35元，下跌1.68%，换手率0.65%，成交量3.76万手，成交额6151.6万元。公司公告汇总圣湘生物科技股份有限公司关于自愿披露相关产品取得医疗器械注册证的公告副流感病毒、人鼻病毒、腺病毒、肺炎支原体核酸检测试剂盒获得国家药品监督管理局颁发的医疗器械注册证，注册证编号为国械注准20263402137，有效期至2031年10月8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400002026.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK1583","688289","BK1100","09996","BK0239","159883"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675105804","title":"股市必读：安图生物新发布《安图生物关于公司及子公司获得医疗器械注册证的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2675105804","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675105804?lang=zh_cn&edition=full","pubTime":"2026-10-13 01:53","pubTimestamp":1791827590,"startTime":"0","endTime":"0","summary":"公司公告汇总：安图生物及子公司获多项医疗器械注册证，涵盖HIV核酸检测试剂盒、全自动凝血分析仪等，注册证有效期均为5年。公司公告汇总安图生物关于公司及子公司获得医疗器械注册证的公告郑州安图生物工程股份有限公司及全资子公司安图实验仪器（郑州）、二级子公司郑州标源近日收到国家药品监督管理局和河南省药品监督管理局颁发的医疗器械注册证。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101300001865.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159883","BK0046","09996","BK1574","BK0239","BK1583","BK1100","603658"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674806993","title":"科华生物（002022）披露控股子公司产品获得医疗器械注册证，10月12日股价下跌2.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674806993","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674806993?lang=zh_cn&edition=full","pubTime":"2026-10-12 23:06","pubTimestamp":1791817578,"startTime":"0","endTime":"0","summary":"截至2026年10月12日收盘，科华生物报收于6.07元，较前一交易日下跌2.1%，最新总市值为32.26亿元。该股当日开盘6.2元，最高6.26元，最低6.01元，成交额达7774.14万元，换手率为2.47%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200036252.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","002022","159883","BK0239","BK0188","09996","BK1574","BK1583","BK1100","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674089578","title":"心泰医疗(02291)：MemoCarna®氧化膜单铆卵圆孔未闭封堵器取得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2674089578","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674089578?lang=zh_cn&edition=full","pubTime":"2026-10-12 21:18","pubTimestamp":1791811101,"startTime":"0","endTime":"0","summary":"智通财经APP讯，心泰医疗 发布公告，公司的全资附属公司上海形状记忆合金材料有限公司已取得中国国家药品监督管理局就MemoCarna氧化膜单铆卵圆孔未闭封堵器产品授出的医疗器械注册证。经导管封堵是PFO的重要治疗手段，而术后残余分流仍是临床面临的问题。连同公司此前已取得医疗器械注册证的MemoSorb生物可降解卵圆孔未闭封堵器，该产品的获批上市进一步丰富了公司在卵圆孔未闭封堵治疗领域的产品组合，为临床提供不同技术路径的介入治疗选择。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1506152.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LGHT","PTH","AGNG","RSPH","GDOC","HART","BK1574","09996","BK1100","LNGR","MEDX","MDEV","159883","IEIH","BK1583","02291"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674487762","title":"圣湘生物最新公告：第二款冻干四联检产品取得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2674487762","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674487762?lang=zh_cn&edition=full","pubTime":"2026-10-12 20:00","pubTimestamp":1791806448,"startTime":"0","endTime":"0","summary":"圣湘生物(688289.SH)公告称，公司产品副流感病毒、人鼻病毒、腺病毒、肺炎支原体核酸检测试剂盒(荧光PCR法)近日取得国家药监局颁发的《医疗器械注册证》，注册证有效期至2031年10月8日。该产品系公司继首款冻干四联检产品后推出的第二款冻干四联检产品，基于AI驱动的酶进化技术，实现8种常见呼吸道病原的互补覆盖，适配分子POCT平台及常规PCR检测平台。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200030994.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","688289","BK1100","BK0239","09996","BK1583","159883"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674873027","title":"博晖创新最新公告：获得结核分枝杆菌检测试剂盒医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2674873027","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674873027?lang=zh_cn&edition=full","pubTime":"2026-10-12 17:21","pubTimestamp":1791796900,"startTime":"0","endTime":"0","summary":"博晖创新(300318.SZ)公告称，公司近日获得国家药品监督管理局颁发的医疗器械注册证，产品为结核分枝杆菌复合群及利福平、异烟肼耐药基因突变检测试剂盒(芯片杂交法)，注册分类为Ⅲ类，有效期至2031年10月8日。该产品用于体外定性检测人痰液样本中结核分枝杆菌复合群核酸及相关耐药基因突变。此次注册证的取得丰富了公司产品种类，有利于提升核心竞争力和市场拓展能力，但实际销售情况受市场推广等因素影响存在不确定性。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200022821.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","159883","BK0048","BK0251","BK1100","300318","BK1583","09996","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674820392","title":"科华生物(002022.SZ)：诺如病毒GⅠ和GⅡ型核酸分型检测试剂盒(荧光PCR法)获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2674820392","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674820392?lang=zh_cn&edition=full","pubTime":"2026-10-12 16:04","pubTimestamp":1791792276,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科华生物(002022.SZ)发布公告，近日，公司控股子公司苏州天隆生物科技有限公司收到国家药品监督管理局颁发的医疗器械注册证(体外诊断试剂)，该产品为：“诺如病毒GⅠ和GⅡ型核酸分型检测试剂盒(荧光PCR法)”。本试剂盒用于体外定性分型检测粪便样本中诺如病毒GⅠ和GⅡ型核酸RNA。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1505842.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["002022","IEIH","BK1583","GDOC","MEDX","159883","BK0239","BK0188","PTH","HART","LNGR","BK0046","BK1100","AGNG","PCR","MDEV","RSPH","09996","BK1574","BK0028","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674845784","title":"股市必读：东方海洋新发布《关于子公司取得医疗器械注册证的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674845784","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674845784?lang=zh_cn&edition=full","pubTime":"2026-10-12 02:40","pubTimestamp":1791744022,"startTime":"0","endTime":"0","summary":"公司公告汇总：子公司质谱生物科技有限公司取得水溶性维生素测定试剂盒医疗器械注册证，有效期至2031年9月29日。公司公告汇总关于子公司取得医疗器械注册证的公告山东东方海洋科技股份有限公司子公司质谱生物科技有限公司自主研发的水溶性维生素测定试剂盒近日取得山东省药品监督管理局的医疗器械注册证，注册证编号为鲁械注准20262400380，有效期至2031年9月29日，预期用途为体外定量检测人血清中多种维生素B成分。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200000866.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1100","BK1583","BK0092","BK1574","002086","BK0213","159883","09996","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674812686","title":"凯普生物最新公告：全资子公司取得医疗器械注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2674812686","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674812686?lang=zh_cn&edition=full","pubTime":"2026-10-11 17:20","pubTimestamp":1791710449,"startTime":"0","endTime":"0","summary":"凯普生物(300639.SZ)公告称，公司全资子公司潮州凯普生物化学有限公司取得国家药品监督管理局颁发的医疗器械注册证，产品为阴道微生物核酸检测试剂盒(PCR-荧光探针法)，属III类体外诊断试剂，用于定性检测阴道分泌物中的阴道毛滴虫、阴道加德纳菌及白色念珠菌核酸。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101100006161.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09996","BK1100","BK0042","300639","BK1574","BK0046","BK0239","BK1583","159883","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674899603","title":"清华证研院：创新药板块景气修复与医疗器械自主可控构成9月主线","url":"https://stock-news.laohu8.com/highlight/detail?id=2674899603","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674899603?lang=zh_cn&edition=full","pubTime":"2026-10-10 15:28","pubTimestamp":1791617326,"startTime":"0","endTime":"0","summary":"上证报中国证券网讯（记者张玮华）清华大学全球证券市场研究院（以下简称“清华证研院”）发布《中国上市公司市值分析月度报告（2026年9月）》。清华证研院院长助理、中国上市公司市值管理研究负责人迟永胜接受上证报记者采访时表示，9月A股市场整体呈现调整回落、估值同步压缩的运行态势；行业方面，房地产、医药生物、银行等板块逆势上涨，价值防御风格占优特征清晰。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://stock.eastmoney.com/news/11215,202610103891917365.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/news/11215,202610103891917365.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["MEDX","BK1161","BK1583","PTH","159992","IBBQ","IEIH","BK1100","RSPH","AGNG","BK1574","HART","MDEV","LGHT","09996","LNGR","06978","159883","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674858681","title":"九强生物（300406）披露公司及全资子公司取得医疗器械注册证书的公告，10月09日股价上涨1.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674858681","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674858681?lang=zh_cn&edition=full","pubTime":"2026-10-09 17:51","pubTimestamp":1791539479,"startTime":"0","endTime":"0","summary":"截至2026年10月9日收盘，九强生物报收于12.14元，较前一交易日上涨1.68%，最新总市值为71.16亿元。该股当日开盘11.9元，最高12.14元，最低11.77元，成交额达7015.68万元，换手率为1.38%。九强生物于2026年10月8日披露《关于公司及全资子公司取得医疗器械注册证书的公告》。公告显示，北京九强生物技术股份有限公司及全资子公司北京美创新跃医疗器械有限公司近日收到北京市药品监督管理局颁发的5项《医疗器械注册证》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900028224.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK0028","BK0239","BK0012","159883","BK1583","BK1100","BK0046","09996","BK0077","300406"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674002334","title":"股市必读：三鑫医疗新发布《关于全资子公司变更医疗器械生产许可证的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674002334","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674002334?lang=zh_cn&edition=full","pubTime":"2026-10-09 02:32","pubTimestamp":1791484331,"startTime":"0","endTime":"0","summary":"截至2026年10月8日收盘，三鑫医疗报收于9.05元，上涨0.0%，换手率1.17%，成交量4.28万手，成交额3883.49万元。公司公告汇总：全资子公司云南三鑫医疗科技有限公司完成《医疗器械生产许可证》变更，企业负责人由万小平变更为彭海波，许可期限为2026年9月30日至2031年9月29日。公司公告汇总：截至2026年9月30日，公司已回购股份2,489,700股，占总股本0.48%，支付资金22,527,777元，回购进展符合相关规定。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900002355.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK1583","BK1574","09996","159883","BK1100","300453"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673051360","title":"东方海洋（002086）披露子公司取得医疗器械注册证公告，10月08日股价下跌0.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673051360","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673051360?lang=zh_cn&edition=full","pubTime":"2026-10-08 22:46","pubTimestamp":1791470774,"startTime":"0","endTime":"0","summary":"截至2026年10月8日收盘，东方海洋报收于2.01元，较前一交易日下跌0.99%，最新总市值为39.37亿元。该股当日开盘2.03元，最高2.07元，最低1.99元，成交额达7950.19万元，换手率为2.48%。近日，山东东方海洋科技股份有限公司子公司质谱生物科技有限公司自主研发的水溶性维生素测定试剂盒取得山东省药品监督管理局的医疗器械注册证，注册证编号为鲁械注准20262400380，有效期至2031年9月29日，预期用途为体外定量检测人血清中多种维生素B成分。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800034831.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09996","BK1574","BK0046","002086","BK1583","BK0092","BK1100","BK0213","159883"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673002765","title":"东方海洋(002086.SZ)：水溶性维生素测定试剂盒(液相色谱-串联质谱法)取得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2673002765","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673002765?lang=zh_cn&edition=full","pubTime":"2026-10-08 16:43","pubTimestamp":1791449027,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东方海洋(002086.SZ)发布公告，公司子公司质谱生物科技有限公司自主研发的水溶性维生素测定试剂盒(液相色谱-串联质谱法)于近日取得了山东省药品监督管理局的注册批准，获得医疗器械注册证。上述产品获准上市，进一步丰富了质谱生物科技有限公司在临床检测领域的产品线。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1504612.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AGNG","BK1574","LNGR","002086","IEIH","MEDX","09996","LGHT","GDOC","MDEV","PTH","BK1583","HART","BK0046","BK0092","159883","BK0213","BK1100","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673022610","title":"九强生物(300406.SZ)：5款产品取得医疗器械注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2673022610","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673022610?lang=zh_cn&edition=full","pubTime":"2026-10-08 16:23","pubTimestamp":1791447834,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九强生物(300406.SZ)发布公告，公司及全资子公司北京美创新跃医疗器械有限公司(以下简称“美创新跃”)于近日收到北京市药品监督管理局颁发的《医疗器械注册证》，涉及产品：“天门冬氨酸氨基转移酶测定试剂盒(天门冬氨酸底物法)”、“总免疫球蛋白 E测定试剂盒(磁微粒化学发光免疫分析法)”、“抑制素B测定试剂盒(磁微粒化学发光免疫分析法)”、“碱性磷酸酶测定试剂盒(NPP 底物-AMP缓冲液法)”、“凝血酶时间检测试剂盒(凝固法)”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1504584.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MEDX","BK0046","BK1583","PTH","BK0077","IEIH","BK1100","RSPH","BK0028","AGNG","BK1574","HART","MDEV","300406","LGHT","09996","LNGR","BK0012","159883","BK0239","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673293026","title":"营收猛增42%且扭亏为盈! 人工椎间盘领军者Centinel Spine冲刺美股IPO 创新医疗器械迎估值检验","url":"https://stock-news.laohu8.com/highlight/detail?id=2673293026","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673293026?lang=zh_cn&edition=full","pubTime":"2026-10-08 14:44","pubTimestamp":1791441889,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，美国知名医疗器械制造商Centinel Spine当地时间周三在提交的美国股市首次公开募股申报文件中披露，上半年营收大幅增长42%。Centinel Spine此次递交IPO申请，可谓为全球聚焦于医疗器械的投资者们提供了一个“技术商业化、收入增长与盈利改善同步加速推进”的观察样本。目前该公司尚未完成IPO发行与最终的估值定价。Centinel Spine计划将此次发行募集的资金用于偿还债务，并投资于销售基础设施、患者宣传教育项目、临床试验等方面。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1504538.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AGNG","IEIH","MDEV","IPOS","LGHT","LNGR","KCE","GDOC","FRHC","REDS","RSPH","159883","09996","MEDX","PTH","HART"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673301493","title":"股市必读：安图生物新发布《安图生物关于全资子公司完成医疗器械经营许可证及药品经营许可证变更登记的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2673301493","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673301493?lang=zh_cn&edition=full","pubTime":"2026-10-08 01:10","pubTimestamp":1791393017,"startTime":"0","endTime":"0","summary":"截至2026年9月30日收盘，安图生物报收于34.08元，上涨1.4%，换手率0.62%，成交量3.55万手，成交额1.21亿元。医疗器械经营许可证经营范围涵盖多个类别，经营方式为批零兼营并提供运输、贮存服务，许可期限至2030年5月21日；药品经营许可证经营范围为体外诊断试剂（药品），含冷藏药品，经营方式为批发，有效期至2029年6月27日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800000754.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159883","BK0046","09996","BK1574","BK0239","BK1583","BK1100","603658"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.peijiamedical.com","stockEarnings":[{"period":"1week","weight":-0.1035},{"period":"1month","weight":-0.1153},{"period":"3month","weight":-0.0169},{"period":"6month","weight":-0.3838},{"period":"1year","weight":-0.2863},{"period":"ytd","weight":-0.272}],"compareEarnings":[{"period":"1week","weight":0.0076},{"period":"1month","weight":-0.0242},{"period":"3month","weight":-0.0278},{"period":"6month","weight":-0.0706},{"period":"1year","weight":-0.0443},{"period":"ytd","weight":-0.0514}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"沛嘉医疗有限公司是一家主要提供介入手术医疗器械产品的投资控股公司。该公司主要运营两个业务分部，经导管瓣膜治疗业务分部和神经介入业务分部。经导管瓣膜治疗业务分部主要从事研发、制造及销售经导管瓣膜治疗医疗器械业务。神经介入业务分部主要从事研发、制造及销售神经介入手术医疗器械业务。该公司的产品包括TaurusOne、TaurusElite等商业化产品。该公司主要在中国境内开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.057115},{"month":2,"riseRate":0.5,"avgChangeRate":0.017515},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.100991},{"month":4,"riseRate":0.8,"avgChangeRate":0.053778},{"month":5,"riseRate":0.6,"avgChangeRate":-0.096849},{"month":6,"riseRate":0.571429,"avgChangeRate":0.041819},{"month":7,"riseRate":0.571429,"avgChangeRate":0.044814},{"month":8,"riseRate":0.428571,"avgChangeRate":-0.034075},{"month":9,"riseRate":0.285714,"avgChangeRate":0.002992},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.017542},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.027135},{"month":12,"riseRate":0.666667,"avgChangeRate":0.083675}],"exchange":"SEHK","name":"沛嘉医疗-B","nameEN":"PEIJIA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供沛嘉医疗-B(09996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"沛嘉医疗-B,09996,沛嘉医疗-B股票,沛嘉医疗-B股票老虎,沛嘉医疗-B股票老虎国际,沛嘉医疗-B行情,沛嘉医疗-B股票行情,沛嘉医疗-B股价,沛嘉医疗-B股市,沛嘉医疗-B股票价格,沛嘉医疗-B股票交易,沛嘉医疗-B股票购买,沛嘉医疗-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供沛嘉医疗-B(09996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}